Post by Element Biosciences

We are thrilled to announce our Series E round of financing, which includes $175 million from Samsung Electronics. "This financing represents a powerful vote of confidence in our vision, our technology, and our team's ability to execute. At a time when many life science companies continue to face significant market challenges, the support of both new and existing investors validates the progress we have made in building a differentiated portfolio of products and bringing them successfully to customers." - Molly He, CEO and Co-Founder of Element This new capital directly supports the commercialization and adoption of our growing ecosystem of genomic and multiomic technologies, including AVITI™, VITARI™, upcoming tissue applications on AVITI24™, and AVITI Dx™. Most importantly, it enables us to accelerate our mission of empowering researchers with transformative technologies that advance scientific discovery, support the future of precision medicine, and ultimately improve human health. Learn more: https://bit.ly/4fAEkrI. #AVITI #AVITI24 #VITARI